Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Andy J. Kaempf"'
Autor:
Luai S. Al Rabadi, Madeline M. Cook, Andy J. Kaempf, Megan M. Saraceni, Michael A. Savin, Zahi I. Mitri
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-8 (2021)
Abstract Background Docetaxel in combination with two HER2-directed therapies, trastuzumab and pertuzumab, is the current standard frontline therapy for patients with metastatic HER2-positive breast cancer. Ado-trastuzumab (T-DM1), an antibody-drug c
Externí odkaz:
https://doaj.org/article/2659c47324254f67bf9628d1989ae754
